Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
Ucom Supports Free FPV Drone Training for Teenagers by the ArmDrone Community AraratBank’s Special Offer at Leasing Expo Attracts Strong Customer Interest Flexible Terms when Transferring your Mortgage Loan to AraratBankThe Defense Team of the “Sacred Struggle” Releases Evidence Exposing a Fabricated Terrorism Case Unibank Awarded Client Protection Certification by MFR The Power of One Dram April Beneficiary: Davitbek Games NGOUcom and Impact Hub Yerevan Announce the Third Year of Green Innovation FellowshipUnibank Launches Referral Campaign “Invite Friends and Get Bonuses"Team Holding: The second phase of the placement of USD-denominated bonds has been completed. Underwriter - Freedom Broker Armenia. “A friend” needs money urgently. IDBank warns that trust can be exploited on social media.Denationalizing the ‘Map’ (Reflections on the ‘Real Armenia Ideology’)AraratBank at Leasing EXPO 2026: Special Leasing Offer for Energy-Efficient EquipmentUcom Offers Virtual Cloud Server (VPS) ServiceIDBank Participates in Regional Conference of the Union of Banks of Armenia, Presenting Innovative Tools for the SME SectorUp to 25% idcoin When Buying Airline Tickets with IDBank Premium CardsAcba bank and the U.S.-based Interactive Brokers have signed an agreementIDBank and Idram Alongside the “Matemik” NGOIDBank Participates in Regional Conference of the Union of Banks of ArmeniaConverse Bank Receives STP Excellence Award Once AgainUnibank to participate in Leasing Expo 2026 with a special offer
All Timeline »
Life

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.